WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
I'm a cruise ship worker...these are the FIVE things smart passengers always do onboard
Humanitarian crisis in Gaza exposes Western double standard on human rights
The Village Super League and the rural awakening
China's top procuratorate releases typical real
Judge blocks Biden administration from enforcing new gun sales background check rule in Texas
Scaloni: Messi key in decision to remain Argentina boss
3 dead in east China residential complex fire
Flood relief work strengthened in China's Guangdong
Jude Bellingham's new model girlfriend Laura Celia Valk looks sensational in a figure
Spring Festival spending highlights momentum of China's economy